In IBM patients, mregDC cells expressed significantly higher levels of IL15 than in non-IBM patients and trended towards increased expression of other co-stimulatory, co-inhibitory, and HLA genes without reaching statistical significance (Extended Data Table 1). The gene discussed is IL15; the disease is inclusion body myositis.